Dr. Christopher P. O'carroll, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 51
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 451
Licensed in California since 1982, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CA license A38693 (first issued 1982; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hoag Memorial Hospital Presbyterian Newport Beach, CA
Medical groups
- C Philip O Carroll M D Inc (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 451
- Services billed
- 110,025
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 98,800 | 147 |
| Established patient office or other outpatient visit, 30-39 minutes | 449 | 168 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 397 | 123 |
| Psychiatric services complicated by communication factor | 192 | 12 |
| Psychotherapy with evaluation and management visit, 1 hour | 192 | 12 |
| New patient office or other outpatient visit, 60-74 minutes | 123 | 123 |
| Established patient office or other outpatient visit, 40-54 minutes | 120 | 100 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 65 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Newport Beach, CA | 479 |
| Sumatriptan Succinate Other prescribers in Newport Beach, CA | 455 |
| Gabapentin Other prescribers in Newport Beach, CA | 432 |
| Clonazepam Other prescribers in Newport Beach, CA | 415 |
| Oxycodone Hcl Other prescribers in Newport Beach, CA | 296 |
| Alprazolam Other prescribers in Newport Beach, CA | 265 |
| Lorazepam Other prescribers in Newport Beach, CA | 260 |
| Rizatriptan (rizatriptan benzoate) Other prescribers in Newport Beach, CA | 255 |
| Butalbital-Acetaminophen-Caffe (butalb/acetaminophen/caffeine) Other prescribers in Newport Beach, CA | 244 |
| Duloxetine Hcl Other prescribers in Newport Beach, CA | 235 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 26 companies reported 273 payments worth $46,787 in total to this clinician.
| Axsome Therapeutics, Inc. | $21,425 |
|---|---|
| Pfizer Inc. | $9,069 |
| AbbVie Inc. | $7,455 |
| Lundbeck LLC | $6,140 |
| UCB, Inc. | $708 |
| Alexion Pharmaceuticals, Inc. | $331 |
| Teva Pharmaceuticals USA, Inc. | $254 |
| Neurocrine Biosciences, Inc. | $233 |
| Honoraria | $25,539 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $11,550 |
| Food and Beverage | $6,982 |
| Consulting Fee | $2,528 |
| Education | $101 |
| Travel and Lodging | $86.80 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. Jul 17, 2025 | Honoraria Symbravo · Neurology | $4,725 |
| Axsome Therapeutics, Inc. Jul 10, 2025 | Honoraria Symbravo · Neurology | $4,388 |
| Pfizer Inc. Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) NURTEC ODT · PAIN | $3,150 |
| Pfizer Inc. Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) NURTEC ODT · PAIN | $3,150 |
| Axsome Therapeutics, Inc. Oct 22, 2025 | Honoraria Symbravo · Neurology | $3,038 |
| Axsome Therapeutics, Inc. Oct 9, 2025 | Honoraria Symbravo · Neurology | $3,038 |
| Lundbeck LLC Nov 19, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,910 |
| AbbVie Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA; UBRELVY · NEUROSCIENCE | $2,625 |
| AbbVie Inc. Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $2,625 |
| Lundbeck LLC Feb 19, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,040 |
All 17 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) NURTEC ODT · PAIN | $3,150 |
| Lundbeck LLC Nov 19, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,910 |
| Pfizer Inc. Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) NURTEC ODT · PAIN | $3,150 |
| Axsome Therapeutics, Inc. Oct 22, 2025 | Honoraria Symbravo · Neurology | $3,038 |
| Lundbeck LLC Oct 15, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $728 |
| Axsome Therapeutics, Inc. Oct 9, 2025 | Honoraria Symbravo · Neurology | $3,038 |
| Pfizer Inc. Sep 30, 2025 | Consulting Fee NURTEC ODT · PAIN | $1,800 |
| Axsome Therapeutics, Inc. Sep 23, 2025 | Honoraria Symbravo · Neurology | $1,350 |
| Teva Pharmaceuticals USA, Inc. Aug 28, 2025 | Education in-kind | $101 |
| Axsome Therapeutics, Inc. Jul 28, 2025 | Honoraria Symbravo · Neurology | $2,025 |
| Axsome Therapeutics, Inc. Jul 17, 2025 | Honoraria Symbravo · Neurology | $4,725 |
| Axsome Therapeutics, Inc. Jul 15, 2025 | Honoraria Symbravo · Neurology | $2,025 |
| Axsome Therapeutics, Inc. Jul 10, 2025 | Honoraria Symbravo · Neurology | $4,388 |
| Axsome Therapeutics, Inc. Jul 10, 2025 | Travel and Lodging Symbravo · Neurology · travel to Redlands, CA | $86.80 |
| AbbVie Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA; UBRELVY · NEUROSCIENCE | $2,625 |
| AbbVie Inc. Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $2,625 |
| Lundbeck LLC Feb 19, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,040 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,064 in research payments for these studies, mostly to the institutions running them.
- Preventive treatment of migraine: outcomes for patients in real-world healthcare systems (triumph)
Eli Lilly and Company
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.